Shilpa Medicare delivered a strong year-on-year performance in the third quarter ended 31 December 2025, with healthy growth across both revenue and profitability, despite cost pressures visible at the operating level.
For Q3 FY26, Shilpa Medicare reported revenue from operations of ₹409.73 crore, compared with ₹319.30 crore in the corresponding quarter last year. This translates into a YoY growth of around 28.3%, driven primarily by higher net sales and improved scale of operations. Total income for the quarter stood at ₹410.54 crore, up from ₹320.48 crore in Q3 FY25, marking a YoY increase of about 28.1%.
On the profitability front, profit before tax (after exceptional items) came in at ₹60.85 crore, compared with ₹41.61 crore a year ago, reflecting a YoY growth of nearly 46.2%. The sharp improvement was supported by better operating leverage and the impact of exceptional income during the quarter.
Net profit attributable to owners of the parent company rose to ₹44.58 crore in Q3 FY26 from ₹31.78 crore in Q3 FY25. This represents a strong YoY growth of approximately 40.3%, highlighting improved bottom-line performance despite higher employee and finance costs.
At the operating level, total expenses increased to ₹336.47 crore from ₹279.21 crore in the year-ago quarter, a rise of around 20.5% YoY. Employee benefits expense grew by about 13.6% YoY to ₹83.45 crore, while depreciation and amortisation expenses increased marginally by around 5.4% YoY to ₹30.36 crore, reflecting ongoing investments in capacity and capabilities.
